Adjuvant therapy for colon cancer: a historical perspective.
Jean
J
Grem
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D018572:Disease-Free Survival; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009163:Mycobacterium bovis; D009367:Neoplasm Staging; D016017:Odds Ratio; D011237:Predictive Value of Tests; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012673:Semustine / Q000008:administration & dosage; D016019:Survival Analysis; D016896:Treatment Outcome; D014481:United States; D014750:Vincristine / Q000008:administration & dosage
D012673:Semustine; D014750:Vincristine; D005472:Fluorouracil